We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.41%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$18.5B
AUM Growth
+$2.73B
(+17%)
Cap. Flow
+$1.18B
Cap. Flow
% of AUM
6.38%
Top 10 Holdings %
Top 10 Hldgs %
17.08%
Holding
1,449
New
438
Increased
447
Reduced
240
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vodafone
VOD
|
+$224M |
| 2 |
Boeing
BA
|
+$182M |
| 3 |
Bank of America
BAC
|
+$178M |
| 4 |
Citigroup
C
|
+$126M |
| 5 |
JPMorgan Chase
JPM
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$363M |
| 2 |
BP
BP
|
+$245M |
| 3 |
GSK
GSK
|
+$165M |
| 4 |
Nokia
NOK
|
+$142M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.33% |
| 2 | Technology | 18.71% |
| 3 | Healthcare | 16.5% |
| 4 | Communication Services | 12.26% |
| 5 | Industrials | 11.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Canadian National Railway
CNI
$76.2B
| $26.3M | 0.14% |
+461,018
| New | +$25.4M |
|
|
SNDK
152
DELISTED
SANDISK CORP
SNDK
| $26.2M | 0.14% |
370,995
-494,507
| -57% | -$33.3M |
|
153
Community Health Systems
CYH
$415M
| $25.5M | 0.14% |
786,840
+462,314
| +142% | +$15.9M |
|
154
Robert Half
RHI
$4.2B
| $25M | 0.14% |
596,150
+257,885
| +76% | +$10.2M |
|
155
KeyCorp
KEY
$24.1B
| $24.8M | 0.13% |
1,848,335
+1,631,603
| +753% | +$20.6M |
|
156
TIM SA
TIMB
$8.8B
| $24.7M | 0.13% |
942,705
+9,262
| +1% | +$234K |
|
|
XLS
157
DELISTED
EXELIS INC COM STK
XLS
| $24.6M | 0.13% |
1,383,002
+254,113
| +23% | +$4.04M |
|
|
SPR
158
DELISTED
Spirit AeroSystems
SPR
| $24.5M | 0.13% |
717,876
-149,140
| -17% | -$4.39M |
|
|
CAJ
159
DELISTED
Canon, Inc.
CAJ
| $24.3M | 0.13% |
758,835
-345,169
| -31% | -$11M |
|
|
NVO
160
Novo Nordisk
NVO
$208B
| $24.2M | 0.13% |
1,310,760
-423,940
| -24% | -$7.39M |
|
|
SJR
161
DELISTED
Shaw Communications Inc.
SJR
| $24.1M | 0.13% |
+989,304
| New | +$23.4M |
|
162
Invesco
IVZ
$14.1B
| $23.9M | 0.13% |
656,087
+649,101
| +9,291% | +$22M |
|
163
Petrobras Class A
PBR.A
$107B
| $23.6M | 0.13% |
1,607,018
+208,522
| +15% | +$3.43M |
|
|
AGN
164
DELISTED
Allergan plc
AGN
| $23M | 0.12% |
136,828
+115,013
| +527% | +$18M |
|
165
ManpowerGroup
MAN
$2.57B
| $22.6M | 0.12% |
263,471
+137,116
| +109% | +$11M |
|
166
Ford
F
$55.2B
| $22.6M | 0.12% |
1,464,606
-2,250,249
| -61% | -$37.7M |
|
|
WOOF
167
DELISTED
VCA Inc.
WOOF
| $22.5M | 0.12% |
718,714
+353,249
| +97% | +$10.3M |
|
168
America Movil
AMX
$72B
| $22.4M | 0.12% |
959,879
-141,817
| -13% | -$3.09M |
|
169
KT
KT
$8.83B
| $22.3M | 0.12% |
1,499,053
-156,646
| -9% | -$2.46M |
|
|
LLL
170
DELISTED
L3 Technologies, Inc.
LLL
| $22.3M | 0.12% |
208,476
+203,388
| +3,997% | +$20.3M |
|
|
SLXP
171
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $22.1M | 0.12% |
246,244
+146,712
| +147% | +$11.7M |
|
172
Bausch Health
BHC
$2.21B
| $21.7M | 0.12% |
185,193
+113,205
| +157% | +$12.4M |
|
|
VALE.P
173
DELISTED
Vale S A
VALE.P
| $21.7M | 0.12% |
1,550,146
-1,935,775
| -56% | -$27.5M |
|
174
Assurant
AIZ
$14.6B
| $21.6M | 0.12% |
325,938
+105,645
| +48% | +$6.46M |
|
175
Turkcell
TKC
$4.79B
| $21.4M | 0.12% |
1,606,532
+184,249
| +13% | +$2.79M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2013 Portfolio in Review
As of Q4 2013, Arrowstreet Capital held 1,449 positions worth $18.5B, up 17% from $15.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Arrowstreet Capital deployed $1.18B of net new capital in Q4 2013, opening 438 new positions and adding to 447 existing holdings. Its largest new stake was Bank of America: 11,999,441 shares worth $187M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 9.3% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was GSK, an estimated $165M trimmed.
- Arrowstreet Capital's largest Q4 2013 buy was Bank of America: 11,999,441 shares worth $187M.
- Arrowstreet Capital added most to Vodafone in Q4 2013, an estimated $224M increase.
- Arrowstreet Capital's biggest Q4 2013 reduction was GSK, cutting an estimated $165M.
- Arrowstreet Capital fully exited Philip Morris in Q4 2013, selling an estimated $363M.
- Arrowstreet Capital's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2013.
- Arrowstreet Capital opened 438 new positions and closed 319 in Q4 2013.
- Arrowstreet Capital's portfolio value rose 17% quarter-over-quarter to $18.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2013, filed 14 Feb 2014.